首頁 / ETF介紹 / 個別ETF-全部持股
First Trust納斯達克製藥業ETF〈FTXH〉
First Trust納斯達克製藥業ETF(FTXH)-全部持股
資料日期:2024/08/30
個股名稱投資比例(%)持有股數
AbbVie Inc.7.457,319
Pfizer Inc.7.2948,516
Johnson & Johnson6.867,985
Bristol-Myers Squibb Company6.5725,391
Merck & Co.,Inc.6.2210,134
United Therapeutics Corporation4.872,587
Eli Lilly and Company4.25855
Regeneron Pharmaceuticals,Inc.4.09667
Amgen Inc.4.072,353
Vertex Pharmaceuticals Incorporated3.931,528
Gilead Sciences,Inc.3.668,936
Cardinal Health,Inc.3.365,754
Viatris Inc.3.2551,954
Biogen Inc.3.152,969
Zoetis Inc.3.093,249
Organon & Co.2.9525,438
Jazz Pharmaceuticals Plc2.854,742
Halozyme Therapeutics,Inc.1.845,558
Charles River Laboratories International,Inc.1.541,507
Perrigo Company Plc1.248,228
Medpace Holdings,Inc.1.19645
Incyte Corporation1.053,091
Alkermes Plc0.996,716
Exelixis,Inc.0.947,005
Prestige Consumer Healthcare Inc.0.782,027
Neurocrine Biosciences,Inc.0.731,115
Elanco Animal Health Incorporated0.728,935
TG Therapeutics,Inc.0.635,212
Arcellx,Inc.0.581,631
Illumina,Inc.0.58859
Krystal Biotech,Inc.0.57563
Kymera Therapeutics,Inc.0.532,101
Rhythm Pharmaceuticals,Inc.0.512,067
Ultragenyx Pharmaceutical Inc.0.511,736
Roivant Sciences Ltd.0.507,846
Exact Sciences Corporation0.501,560
BioMarin Pharmaceutical Inc.0.491,040
Ionis Pharmaceuticals,Inc.0.491,985
Intra-Cellular Therapies,Inc.0.491,292
Merus NV0.491,852
Sarepta Therapeutics,Inc.0.49702
Nuvalent,Inc. (Class A)0.471,067
Blueprint Medicines Corporation0.47959
MoonLake Immunotherapeutics (Class A)0.451,861
IDEAYA Biosciences,Inc.0.412,009
Viking Therapeutics,Inc.0.391,164
ACADIA Pharmaceuticals Inc.0.333,862
Beam Therapeutics Inc.0.312,272
US Dollar0.3160,295
CRISPR Therapeutics AG0.261,066
Arvinas,Inc.0.261,952
相關基金
相關ETF

附註:
一、 績效計算為原幣別報酬,且皆有考慮配息情況。基金配息率不代表基金報酬率,且過去配息率不代表未來配息率。所有基金績效,均為過去績效,不代表未來之績效表現,亦不保證基金之最低投資收益。
二、 基金淨值可能因市場因素而上下波動,基金淨值僅供參考,實際以基金公司公告之淨值為準;海外市場指數類型基金,以交易日當天收盤價為淨值參考價。
三、 上述銷售費用僅供參考,實際費率以各銷售機構為主。
四、 上述資料只供參考用途,嘉實資訊自當盡力提供正確訊息,但如有錯漏或疏忽,本公司或關係企業與其任何董事或任何受僱人,恕不負任何法律責任。
最近查閱的商品
有興趣此檔ETF的網友也看過下列ETF